Literature DB >> 10981001

What do we need to know about non-A-to-E viral hepatitis?

K V Menon1, N N Zein.   

Abstract

The list of potential hepatotrophic viruses continues to grow, with the recent discovery of the GB virus-C, the TT virus, and the SEN virus. Prevalence rates of the GB virus-C have ranged from 1.2% to 13% among healthy blood donors from all over the world. Higher prevalence rates have been reported among intravenous drug users. Similarly, the TT virus has a global distribution. However, in spite of numerous reports of the presence of both of these viruses in various kinds of liver diseases, definite evidence linking it to a specific disease or illness is lacking. The SEN virus is thought to be a novel viral agent that may be linked to cryptogenic chronic hepatitis, but data are awaited.

Entities:  

Mesh：

Year:  2000        PMID： 10981001     DOI： 10.1007/s11894-000-0049-1

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN： 1522-8037


  66 in total

1.  GB virus C/hepatitis G virus groups and subgroups: classification by a restriction fragment length polymorphism method based on phylogenetic analysis of the 5' untranslated region.

Authors:  J F Quarleri; V L Mathet; M Feld; D Ferrario; M P della Latta; R Verdun; D O Sánchez; J R Oubiña
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

2.  Susceptibility of TT virus to interferon therapy.

Authors:  K Chayama; M Kobayashi; A Tsubota; M Kobayashi; Y Arase; Y Suzuki; S Saitoh; N Murashima; K Ikeda; K Okamoto; M Hashimoto; M Matsuda; H Koike; M Kobayashi; H Kumada
Journal:  J Gen Virol       Date:  1999-03       Impact factor: 3.891

3.  Prevalence of infection with TT virus (TTV), a novel DNA virus, in healthy Japanese subjects, newborn infants, cord blood and breast milk.

Authors:  H Toyoda; M Naruse; S Yokozaki; K Morita; I Nakano; A Itakura; M Okamura; Y Fukuda; T Hayakawa
Journal:  J Infect       Date:  1999-05       Impact factor: 6.072

4.  Sequence diversity of TT virus in geographically dispersed human populations.

Authors:  L E Prescott; D M MacDonald; F Davidson; J Mokili; D I Pritchard; D E Arnot; E M Riley; B M Greenwood; S Hamid; A A Saeed; M O McClure; D B Smith; P Simmonds
Journal:  J Gen Virol       Date:  1999-07       Impact factor: 3.891

5.  The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease.

Authors:  H J Alter; Y Nakatsuji; J Melpolder; J Wages; R Wesley; J W Shih; J P Kim
Journal:  N Engl J Med       Date:  1997-03-13       Impact factor: 91.245

6.  TT-virus infection in North American blood donors, patients with fulminant hepatic failure, and cryptogenic cirrhosis.

Authors:  M Charlton; P Adjei; J Poterucha; N Zein; B Moore; T Therneau; R Krom; R Wiesner
Journal:  Hepatology       Date:  1998-09       Impact factor: 17.425

7.  Prevalence of TT virus infection in blood donors with elevated ALT in the absence of known hepatitis markers.

Authors:  P J Cleavinger; D H Persing; H Li; S B Moore; M R Charlton; C Sievers; T M Therneau; N N Zein
Journal:  Am J Gastroenterol       Date:  2000-03       Impact factor: 10.864

8.  Clinical significance of TT virus infection in patients with chronic hepatitis C.

Authors:  N N Zein; M Arslan; H Li; M R Charlton; J B Gross; J J Poterucha; T M Therneau; C P Kolbert; D H Persing
Journal:  Am J Gastroenterol       Date:  1999-10       Impact factor: 10.864

9.  Hepatitis G virus infection in patients with hepatitis C virus infection undergoing liver transplantation.

Authors:  M Berenguer; N A Terrault; M Piatak; A Yun; J P Kim; J Y Lau; J R Lake; J R Roberts; N L Ascher; L Ferrell; T L Wright
Journal:  Gastroenterology       Date:  1996-12       Impact factor: 22.682

10.  Aplastic anemia and viral hepatitis. Non-A, Non-B, Non-C?

Authors:  J R Hibbs; N Frickhofen; S J Rosenfeld; S M Feinstone; S Kojima; A Bacigalupo; A Locasciulli; A G Tzakis; H J Alter; N S Young
Journal:  JAMA       Date:  1992-04-15       Impact factor: 56.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.